As part of the U.S. Government’s Initiative for Global Vaccine Access, known as Global VAX, PQM+ is strengthening regulatory and manufacturing capacity in six African countries, including South Africa.
PQM+ works with the South African Health Products Regulatory Authority (SAHPRA), an agency under the National Department of Health, to strengthen the national capacity for vaccine regulation and biomanufacturing, including vaccine quality surveillance and good distribution practices.
In partnership with SAHPRA, Afrigen, Biovac, and other international partners, such as World Health Organization, the Coalition for Epidemic Preparedness Innovations (CEPI), International Vaccine Institute (IVI). PQM+ also builds the capacity of the regulatory workforce by conducting vaccine manufacturing workshops and study visits.
Impact stories and news
- USAID announces technology transfer of novel process to produce API for key TB medicine, lowering cost and increasing availability
- Global VAX workshop held in South Africa
- GlobalVAX funding supports expanded access to vaccines in six PQM+ countries
Office
Centurion, South Africa
